Skip to main content

Advertisement

SpringerLink
Log in

HIV-associated renal disorders: Recent insights into pathogenesis and treatment

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Renal electrolyte disorders, acute renal failure, and a variety of chronic renal diseases are common in HIV-infected patients. Glomerular disorders include IgA nephropathy, cryoglobulinemia, amyloidosis, and a lupus-like immune complex glomerulopathy. The most attention has been focused on collapsing glomerulopathy associated with nephrotic syndrome and progressive renal failure, which appears to be unique for patients with HIV/AIDS, called HIV-associated nephropathy (HIVAN), and it occurs predominantly in African American patients. Investigations in humans and in a transgenic mouse model reveal direct infection of renal epithelial cells by HIV and toxic cellular and immunologic processes mediated by HIV glycoproteins as the principal pathophysiology of HIVAN. Highly active antiretroviral treatment may be associated with an improved renal outcome and even reversal of kidney disease in some patients. Treatment with angiotensin-converting enzyme inhibitors may avert progression of HIVAN to end-stage kidney disease and result in superior patient and kidney survival as compared with untreated patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rao TK, Filippone EJ, Nicastri AD, et al.: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984, 310:669–673.

    Article  PubMed  CAS  Google Scholar 

  2. Pardo V, Aldana M, Colton RM, et al.: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984, 101:429–434.

    PubMed  CAS  Google Scholar 

  3. Gardenswartz MH, Lerner CW, Seligson GR, et al.: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984, 21:197–204.

    PubMed  CAS  Google Scholar 

  4. Ortiz-Butcher C: The spectrum of kidney diseases in patients with human immunodeficiency virus infection. Curr Opin Nephrol Hypertens 1993, 2:355–364. Renal involvement in HIV-infected patients is described here in detail, including common electrolyte and acid-base problems. This is one of the best studies on the fluid, electrolyte, and acid-based problems seen in HIV patients.

    Article  PubMed  CAS  Google Scholar 

  5. Szczech LA, Gupta SK, Habash R, et al.: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004, 66:1145–1152. This is a comprehensive biopsy study of 89 patients from six medical centers documenting the main types of chronic renal diseases, their clinical course, and natural history.

    Article  PubMed  Google Scholar 

  6. Ross MJ, Klotman PE: HIV-associated nephropathy. AIDS 2004, 18:1089–1099.

    Article  PubMed  Google Scholar 

  7. Kimmel PL, Barisoni L, Kopp JB: Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003, 139:214–226. A detailed discussion of the epidemiologic, clinical, and pathologic aspects of HIV-associated renal diseases with a succinct description of the transgenic mouse model.

    PubMed  CAS  Google Scholar 

  8. Herman ES, Klotman PE: HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment. Semin Nephrol 2003, 23:200–208.

    Article  PubMed  Google Scholar 

  9. US Renal Data System: USRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1999.

    Google Scholar 

  10. Cusano AJ, Thies HL, Siegal FP, et al.: Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990, 3:949–953.

    PubMed  CAS  Google Scholar 

  11. Maesaka JK, Fishbane S: Regulation of renal urate excretion: a critical review. Am J Kidney Dis 1998, 32:917–933.

    PubMed  CAS  Google Scholar 

  12. Spichler AS, Seguro AC: Electrolyte disturbances may predispose nucleoside analogue-treated AIDS patients to acute renal failure. Int J Infect Dis 2004, 8:377–378.

    Article  PubMed  Google Scholar 

  13. Earle KE, Seneviratne T, Shaker J, Shoback D: Fanconi’s syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res 2004, 19:714–721.

    Article  PubMed  Google Scholar 

  14. Morris AA, Baudouin SV, Snow MH: Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. AIDS 2001, 15:140–141.

    Article  PubMed  CAS  Google Scholar 

  15. Maesaka JK, Cusano AJ, Thies HL, et al.: Hypouricemia in acquired immunodeficiency syndrome. Am J Kidney Dis 1990, 15:252–257.

    PubMed  CAS  Google Scholar 

  16. Hansen AB, Mathiesen S, Gerstoft J: Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir. Scand J Infect Dis 2004, 36:389–392.

    Article  PubMed  Google Scholar 

  17. Rao TK: Acute renal failure syndromes in human immunodeficiency virus infection. Semin Nephrol 1998, 18:378–395.

    PubMed  CAS  Google Scholar 

  18. Callens S, De Roo A, Colebunders R: Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir. J Infect 2003, 47:262–263.

    Article  PubMed  Google Scholar 

  19. Joshi MK, Liu HH: Acute rhabdomyolysis and renal failure in HIV-infected patients: risk factors, presentation, and pathophysiology. AIDS Patient Care STDS 2000, 14:541–548.

    Article  PubMed  CAS  Google Scholar 

  20. Nadler RB, Rubenstein JN, Eggener SE, et al.: The etiology of urolithiasis in HIV infected patients. J Urol 2003, 169:475–477.

    Article  PubMed  CAS  Google Scholar 

  21. Meraviglia P, Angeli E, Del Sorbo F, et al.: Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index. AIDS 2002, 16:2089–2093.

    Article  PubMed  Google Scholar 

  22. Alpers CE: Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy. Kidney Int 2003, 63:385–396.

    Article  PubMed  Google Scholar 

  23. Hymes KB, Karpatkin S: Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997, 34:117–125.

    PubMed  CAS  Google Scholar 

  24. Weiner NJ, Goodman JW, Kimmel PL: The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int 2003, 63:1618–1631.

    Article  PubMed  Google Scholar 

  25. Tabechian D, Pattanaik D, Suresh U, et al.: Lupus-like nephritis in an HIV-positive patient: report of a case and review of the literature. Clin Nephrol 2003, 60:187–194.

    PubMed  CAS  Google Scholar 

  26. D’Agati V, Appel GB: Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998, 18:406–421.

    PubMed  CAS  Google Scholar 

  27. Szczech LA: Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis 2001, 33:115–119.

    Article  PubMed  CAS  Google Scholar 

  28. Izzedine H, Francois M, Deray G: Severe nephrotic syndrome without oedema in a patient with HIV-associated nephropathy. Nephrol Dial Transplant 1999, 14:2522–2523.

    Article  PubMed  CAS  Google Scholar 

  29. Guardia JA, Ortiz-Butcher C, Bourgoignie JJ: Oncotic pressure and edema formation in hypoalbuminemic HIV-infected patients with proteinuria. Am J Kidney Dis 1997, 30:822–828.

    PubMed  CAS  Google Scholar 

  30. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int 1999, 56:2203–2213.

    Article  PubMed  CAS  Google Scholar 

  31. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al.: HIV-associated immune-mediated renal disease. Kidney Int 1993, 44:1327–1340.

    PubMed  CAS  Google Scholar 

  32. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, et al.: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 1993, 43:1347–1352.

    PubMed  CAS  Google Scholar 

  33. Marras D, Bruggeman LA, Gao F, et al.: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002, 8:522–526.

    Article  PubMed  CAS  Google Scholar 

  34. Winston JA, Bruggeman LA, Ross MD, et al.: Nephropathy and establishment of a renal reservoir of HIV type-1 during primary infection. N Engl J Med 2001, 344:1979–1984.

    Article  PubMed  CAS  Google Scholar 

  35. Kapasi AA, Patel G, Franki N, Singhal PC: HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation. Mol Med 2002, 8:676–685.

    PubMed  CAS  Google Scholar 

  36. Dickie P, Roberts A, Uwiera R, et al.: Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 2004, 322:69–81.

    Article  PubMed  CAS  Google Scholar 

  37. Ross MJ, Bruggeman LA, Wilson PD, Klotman PE: Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J Am Soc Nephrol 2001, 12:2645–2651.

    PubMed  CAS  Google Scholar 

  38. Bruggeman LA, Dikman S, Meng C, et al.: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997, 100:84–92.

    Article  PubMed  CAS  Google Scholar 

  39. Kopp JB, Klotman ME, Adler SH, et al.: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 1992, 89:1577–1581.

    Article  PubMed  CAS  Google Scholar 

  40. Yamamoto T, Noble NA, Miller DE, et al.: Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int 1999, 55:579–592.

    Article  PubMed  CAS  Google Scholar 

  41. Bodi I, Kimmel PL, Abraham AA, et al.: Renal TGF-beta in HIVassociated kidney diseases. Kidney Int 1997, 51:1568–1577.

    Article  PubMed  CAS  Google Scholar 

  42. Kapasi A, Bhat P, Singhal PC: Tubular cell and HIV-1 gp120 interaction products promote migration of monocytes. Inflammation 1998, 22:137–144.

    Article  PubMed  CAS  Google Scholar 

  43. Scheurer D: Rapid reversal of renal failure after initiation of HAART: a case report. AIDS Read 2004, 14:443–447.

    PubMed  Google Scholar 

  44. Foster MH: Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome? Kidney Int 2004, 65:1105–1106.

    Article  PubMed  Google Scholar 

  45. Hedayati SS, Reddan DN, Szczech LA: HIV-associated nephropathy: a review of the epidemiology and clinical course in the HAART era. AIDS Patient Care STDS 2003, 17:57–63.

    Article  PubMed  Google Scholar 

  46. Szczech LA, Edwards LJ, Sanders LL, et al.: Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 2002, 57:336–341.

    PubMed  CAS  Google Scholar 

  47. Wei A, Burns GC, Williams BA, et al.: Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 2003, 64:1462–1471. A non-randomized, controlled, convincing single-center cohort study on the favorable effect of ACEi (fosinopril) therapy on 44 patients with biopsy-proven HIVAN.

    Article  PubMed  CAS  Google Scholar 

  48. Bird JE, Durham SK, Giancarli MR, et al.: Captopril prevents nephropathy in HIV-transgenic mice. J Am Soc Nephrol 1998, 9:1441–1447.

    PubMed  CAS  Google Scholar 

  49. Kimmel PL, Bosch JP, Vassalotti JA: Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 1998, 18:446–458.

    PubMed  CAS  Google Scholar 

  50. Tan HP, Kaczorowski DJ, Basu A, et al.: Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation 2004, 78:1683–1688.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Section-SL45, Tulane Medical School, 1430 Tulane Avenue, 70112-2632, New Orleans, LA, USA

    Ruth Berggren MD & Vecihi Batuman MD

Authors
  1. Ruth Berggren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vecihi Batuman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berggren, R., Batuman, V. HIV-associated renal disorders: Recent insights into pathogenesis and treatment. Curr HIV/AIDS Rep 2, 109–115 (2005). https://doi.org/10.1007/s11904-005-0002-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-005-0002-x

Keywords

Search

Navigation